No takes yet. Share an insight, caveat, or question.
Analysis of lung adenocarcinoma subtypes reveals variations in clinical and biological profiles, indicating potential treatment implications.
Abe et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: